DCM Limited Faces Arbitration Notice by GCD Prime Over Hisar Project Dispute:

DCM Limited Faces Arbitration Notice by GCD Prime Over Hisar Project Dispute

DCM Limited has received an arbitration notice from GCD Prime following the termination of their joint development agreement over delays and alleged contractual breaches in a Hisar housing project.

Company Dragged Into Arbitration Amid JDA Fallout

authorSaloni KumaridateMar 20, 2026
Last update on Mar 20, 2026
DCM Limited Faces Arbitration Notice by GCD Prime Over Hisar Project Dispute DCM Limited has informed the stock exchange that it has received a notice issued by GCD Prime (Developer) through its Advocates under section 21 of the Arbitration and Reconciliation Act 1996. The notice has been issued seeking to initiate arbitration proceedings as per the terms of their Joint Development Agreement (JDA) signed on August 11, 2022. The present disclosure is in continuation of an earlier communication dated November 01, 2025, which was related to the company's issuance of a Notice of Forfeiture and Termination to GCD Prime (referred to as the Developer) in terms of the Joint Development Agreement (‘JDA’) dated August 11, 2025.
DCM Shriram Secures Major Tax Relief of Rs 9.79 Crore in ITAT Ruling; Partial Matter Sent for Review
The dispute arose from delays and alleged violations by the developer in fulfilling its obligations under the terms of the Joint Development Agreement (JDA). As per the company, the developer failed at getting the revocation of the licence's suspension order. This licence is issued by the Government of Haryana for constructing a residential plotted colony at affordable rates. These plots were required to be set up on 67.275 acres of DCM Limited's land located in Hisar, Haryana. Due to these issues, a previous notice dated November 01, 2025, was issued by the company to terminate the agreement and forfeit the amount paid by the developer. It was informed to the developer that the amount paid by it to the company under the agreement would stand terminated after 15 days from the date of receiving the said notice.
Solara Active Pharma Sciences Faces Rs 161.92 Crore Income Tax Demand
The company discloses that presently it is unaware of the anticipated financial impacts of the present action on its position in the market. The aforementioned disclosure has been made under a regulatory filing dated March 19, 2026, addressed to the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), issued under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations”).

About Author

Saloni Kumari

Content Writer

Saloni is a Content Writer with 2+ years of experience at studycafe.in. She writes legal, taxation, and finance related content including GST, Income Tax etc. Skilled in translating complex judicial pronouncements and regulatory developments into clear, and reader-friendly articles. Experienced in covering judgements of ITAT, High Court, GSTAT, and news related to Income Tax, GST, and corporate law. She can be reached at [email protected].
StudyCafe
Delhi, Delhi, India
2389
Up Next

Loading suggestions…